Global Insulin Infusion Pump Market Expected to Exceed USD 14.6 Billion by 2031, Fueled by Smart Diabetes Management Solutions

[New York, 23 June 2025] – According to Clearview Market Insights (CVMI), the global insulin infusion pump market is projected to grow from USD 7.1 billion in 2024 to USD 14.6 billion by 2031, marking a strong CAGR of 10.7%. This growth reflects the increasing global incidence of diabetes, patient demand for precision therapies, and the ongoing integration of AI and mobile health (mHealth) platforms in diabetes care.

“As digital health and chronic disease management converge, insulin pumps are emerging as core tools for proactive glucose control,” said Dr. Aisha Mehra, senior medtech analyst at CVMI. “Next-generation systems offer more than delivery—they offer intelligence.”

Request Sample @ https://clearviewmarketinsights.com/report-details/global-insulin-infusion-pump-market/

Key Market Highlights

• 2024 Market Size: USD 7.1 billion
• 2031 Forecast: USD 14.6 billion
• CAGR: 10.7% (2024–2031)

Top Growth Drivers

• Global Diabetes Surge: Cases of Type 1 and insulin-dependent Type 2 diabetes continue to rise.
• Tech-Driven Preference: Intelligent algorithms, real-time notifications, and seamless CGM integration drive adoption
• Policy Support: The expansion of U.S. Medicare and EU-wide device subsidies enhance pump accessibility.
• Home-Based Use: Post-pandemic care models enhance decentralized diabetes management.

Segment Trends

• Leading Product Type: Patch pumps are growing faster than tethered systems due to their ease of use.
• Fastest-Growing Region: Asia-Pacific, fueled by increased healthcare access in India and China.
• Target End-Users: Home users are increasingly accounting for first-time pump installations.

Competitive Landscape Snapshot (2024)

• Medtronic – 41%: Market leader with hybrid closed-loop capability
• Insulet – XX%: Tubeless convenience with the Omnipod® line
• Tandem – XX%: Smart dosing through Control-IQ™ and Dexcom pairing
• Roche – XX%: Strong European footprint in hospitals
• Others – 10%: Emerging innovation in compact and AI-based pumps

Outlook to 2031

The next phase of growth will be driven by intelligent systems that integrate automated insulin dosing, predictive analytics, and mobile-first user interfaces. Strategies for affordability, reinforcement of cybersecurity, and regional collaborations will determine the future market winners.

For more insights, visit https://clearviewmarketinsights.com/

About Clearview Market Insights:

Clearview Market Insights is a leading market research and consulting firm providing in-depth industry analysis and strategic recommendations for businesses worldwide.

Media contact:

Bhavani K

Marketing and Sales Head

ClearView Market Insights

Mail: sales@clearviewmarketinsights.com

Phone: +1 917-993-7369